Followers | 292 |
Posts | 70230 |
Boards Moderated | 6 |
Alias Born | 09/03/2005 |
![](https://investorshub.advfn.com/uicon/60503.png?cb=1468779789)
Tuesday, December 13, 2022 10:57:26 AM
Beware of the TNXP promotion for sure.
Unlimited number of scam pumpers on the OTC, I’m out.
Recent TNXP News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/16/2024 09:18:38 PM
- Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency • GlobeNewswire Inc. • 08/16/2024 11:00:00 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 10:03:25 AM
- Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit • GlobeNewswire Inc. • 08/13/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:18:07 PM
- Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain • GlobeNewswire Inc. • 08/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 09:22:42 PM
- Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens • GlobeNewswire Inc. • 08/06/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™ • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/30/2024 09:17:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:08:39 PM
- Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain • GlobeNewswire Inc. • 07/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 12:06:45 PM
- Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/24/2024 09:14:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 01:12:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:48:25 PM
- Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 07/10/2024 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/09/2024 08:33:32 PM
- Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering • GlobeNewswire Inc. • 07/09/2024 01:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/08/2024 09:01:36 PM
- Tonix Pharmaceuticals Announces Proposed Public Offering • GlobeNewswire Inc. • 07/08/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 12:05:24 PM
- Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia • GlobeNewswire Inc. • 07/08/2024 12:00:00 PM
- Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program • GlobeNewswire Inc. • 07/01/2024 12:00:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM